Finance

Lists
Q2 2026 earnings • released • EPS miss -46.19% • Revenue beat +107.98%
See results
CLN:SWX
Clariant AG
CHF 9.63
-1.63%
(-0.16) 1D
Aug 4, 5:30:14 PM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for CLN...
Open
CHF 9.70
High
CHF 9.87
Low
CHF 9.54
Mkt. cap
3.20B
Avg. vol.
1.13M
Volume
1.12M
Dividend
4.36%
Quarterly dividend
CHF 0.10
Ex-dividend date
Apr 11, 2011
52-wk high
CHF 9.87
52-wk low
CHF 6.55
EPS
-CHF 0.23
Shares outstanding
331.94M
No. of employees
10K
Open
CHF 9.70
High
CHF 9.87
Low
CHF 9.54
Mkt. cap
3.20B
Avg. vol.
1.13M
Volume
1.12M
Dividend
4.36%
Quarterly dividend
CHF 0.10
Ex-dividend date
Apr 11, 2011
52-wk high
CHF 9.87
52-wk low
CHF 6.55
EPS
-CHF 0.23
Shares outstanding
331.94M
No. of employees
10K
News stories
From sources across the web
Profile
Clariant AG is a Swiss multinational speciality chemical company, formed in 1995 as a spin-off from Sandoz. Headquartered in Muttenz, Switzerland, the public company encompasses 68 subsidiaries in 36 countries. Major manufacturing sites are located in Europe, North America, South America, China, and India. In 2025, sales from continuing operations were 3.915 billion CHF. European and Middle East markets accounted for 42%, Asia-Pacific for 29%, North America and Latin America for 29% of sales in 2025. EBITDA in 2025 was 643 million CHF. Headquarters are officially in Muttenz, but most global functions are officed in a dedicated corporate center in nearby Pratteln, both near Basel, Switzerland. Clariant's three business units are: Care Chemicals, Adsorbents & Additives and Catalysts. Conrad Keijzer has been Clariant's CEO since 1 January 2021. Wikipedia
About Clariant AG
CEOConrad Keijzer
Employees10.1K
Founded1995
Headquarters-
SectorSpeciality chemicals
Last report
Jul 31, 2026
Fiscal period
Q2 2026
EPS / Est. (CHF)
CHF 0.13 / CHF 0.24
-46.19%miss
Revenue / Est. (CHF)
1.86B / 894.00M
+107.98%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
967.00M
967.00M
929.65M
929.65M
Cost of goods sold
674.50M
674.50M
634.30M
634.30M
Cost of revenue
674.50M
674.50M
634.30M
634.30M
Research and development expenses
30.00M
30.00M
28.55M
28.55M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
178.50M
178.50M
169.00M
169.00M
Operating expense
208.50M
208.50M
197.55M
197.55M
Total operating expenses
883.00M
883.00M
831.85M
831.85M
Operating income
84.00M
84.00M
97.80M
97.80M
Other non operating income
-3.00M
-3.00M
-
-
EBT including unusual items
-22.00M
-22.00M
68.10M
68.10M
EBT excluding unusual items
86.50M
86.50M
83.70M
83.70M
Income tax expense
20.50M
20.50M
25.60M
25.60M
Effective tax rate
-93.18%
-93.18%
37.59%
37.59%
Other operating expenses
-
-
-
-
Net income
-50.50M
-50.50M
35.15M
35.15M
Net profit margin
-5.22%
-5.22%
3.78%
3.78%
Earnings per share
-
-
-
-
Interest and investment income
1.50M
1.50M
2.95M
2.95M
Interest expense
-4.00M
-4.00M
-26.30M
-26.30M
Net interest expenses
-2.50M
-2.50M
-23.35M
-23.35M
Depreciation and amortization charges
-
-
-
-
EBITDA
137.00M
137.00M
145.30M
145.30M
Gain or loss from assets sale
-1.00M
-1.00M
50.00K
50.00K
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps